Viridian Therapeutics, Inc.· VRDN

🇺🇸 US · SmallBroad USNASDAQ

HealthcareBiotechnologyWebsite

Price: $20.84
Day: +7.92%
Mkt Cap: $1.88B
52W Range: $13.18 – $34.29
Volume: 2.17M
Beta: 0.94

D25D FrameworkTTM Data

Peer Comparison

Performance vs sector and industry peers across 40 metrics.

Blog

stockoscope.com

Viridian Therapeutics, Inc.

VRDN|Healthcare|Biotechnology

Comparing against 154 sector peers in United States · Small Cap · Healthcare

Peer Comparison

Dimension 2 of 5

Revenue Growth

N/A

Operating Margin

N/A

ROIC

11%ile

-52.3%

FCF Yield

13%ile

-16.2%

Growth & Cash Flow Quality

Percentile ranking across profitability growth and cash generation

EBITDA Growth

14.7%

EBIT Growth

14.5%

Net Income Growth

17.0%

OCF Growth

8.5%

FCF Growth

8.4%

Income Quality

0.84

Returns on Capital (TTM)

ROE(-60.7%)

12%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

ROCE(-52.3%)

12%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

ROA(-45.7%)

10%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

ROIC(-52.3%)

11%ile

Bottom 20%

PoorWeakAdequateStrongExceptional

Profit Margins (TTM)

Gross Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

EBITDA Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

Operating Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

Net Margin(N/A)

N/A

PoorWeakAdequateStrongExceptional

Leverage & Coverage (TTM)

Debt/Equity

59%ile

0.08

Debt/Capital

58%ile

0.07

Net Debt/EBITDA

83%ile

0.36

Interest Coverage

34%ile

-34.61x

Liquidity (TTM)

Current Ratio

89%ile

15.1

Quick Ratio

89%ile

15.1

Cash Ratio

78%ile

3.40

WC Turnover

34%ile

0.09

Operational Efficiency (TTM)

Asset Turnover

15%ile

0.09

DSO

87%ile

0.00

Days Inventory

73%ile

0.00

Cash Conv. Cycle

N/A

TTM: Trailing Twelve Months · EBITDA: Earnings Before Interest, Taxes, Depreciation & Amortization · EBIT: Earnings Before Interest & Taxes · ROA: Return on Assets · ROIC: Return on Invested Capital · ROCE: Return on Capital Employed · ROE: Return on Equity · OCF: Operating Cash Flow · FCF: Free Cash Flow · DSO: Days Sales Outstanding · WC: Working Capital

See the complete picture

The full 5D Framework: Business Quality · Peer Comparison · Valuation · Analyst Sentiment · Smart Money

Explore VRDN on stockoscope.com→

Generated August 5, 2026

For educational purposes only. Not financial advice. Data may be delayed or incomplete.

154 sector peers (United States · Small Cap · Healthcare)

Relative Quality

VRDN Relative Quality Score

Ranked against 154 sector peers in United States · Small Cap · Healthcare

Relative Quality

2.6/5

Adequate

vs 154 sector peers

Peer Rankings (8 of 10 available)

Relative Quality Score of 2.58/5 (Adequate) based on percentile rankings against 154 sector peers in United States · Small Cap · Healthcare. Each pillar shows a 1-5 score plus the cohort percentile (e.g. 95p = top 5%); higher percentiles indicate stronger relative performance.Last updated August 5, 2026.

Top-Line and Profit Growth

How does the company's growth rate compare to peers?

No data for Revenue Growth is available for VRDN, so peer comparison is hidden for this metric. Try another metric.

Margin Efficiency

Does the company maintain better profit margins than peers?

No data for Gross Margin is available for VRDN, so peer comparison is hidden for this metric. Try another metric.

Operational Efficiency

Is the company more operationally efficient than competitors?

Asset Turnover

15th percentile, Poor

Value: 0.09
Percentile: 15%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

VRDN has a ttm asset turnover of 0.09 and ranks at the 15th percentile vs United States · Healthcare sector peers. Poor financial performance.

Returns Overview

Does the company generate better returns on capital than peers?

ROA

10th percentile, Poor

Value: -45.70%
Percentile: 10%
Score: 1/5

PoorWeakAdequateStrongExceptional

Analysis

VRDN has a ttm roa of -45.70% and ranks at the 10th percentile vs United States · Healthcare sector peers. Poor financial performance.

Cash Flow Quality

How does the company's cash generation compare to peers?

Operating Cash Flow Growth

50th percentile, Adequate

Value: 8.45%
Percentile: 50%
Score: 3/5

PoorWeakAdequateStrongExceptional

Analysis

VRDN has a ttm operating cash flow growth of 8.45% and ranks at the 50th percentile vs United States · Healthcare sector peers. Adequate financial performance.

Liquidity and Working Capital

Does the company maintain better liquidity positions than competitors?

Cash Ratio

78th percentile, Strong

Value: 3.40
Percentile: 78%
Score: 4/5

PoorWeakAdequateStrongExceptional

Analysis

VRDN has a ttm cash ratio of 3.40 and ranks at the 78th percentile vs United States · Healthcare sector peers. Strong financial performance.

Leverage and Coverage

Is the company's debt burden more manageable than peers?

Debt to Capital

58th percentile, Adequate

Value: 0.07
Percentile: 58%
Score: 3/5

PoorWeakAdequateStrongExceptional

Analysis

VRDN has a ttm debt-to-capital of 0.07 and ranks at the 58th percentile vs United States · Healthcare sector peers. Adequate financial performance.

Valuation Multiples

Is the company's stock valuation attractive relative to peers?

P / E Ratio

Insufficient peer data

Value: -5.99
Percentile: n/a
Score: n/a

PoorWeakAdequateStrongExceptional

Analysis

Not enough peer data to rank VRDN for ttm p/e ratio in this cohort.

Dividend and Shareholder Yield

Does the company deliver superior income to shareholders compared to peers?

No data for Dividend Yield is available for VRDN, so peer comparison is hidden for this metric. Try another metric.

Peer companies

The 154 companies VRDN is compared against across its sector and industry cohorts.

Viridian Therapeutics, Inc.· VRDN

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies

Search stocks

Peer Comparison

Top-Line and Profit Growth

Per-Share Fundamentals

Margin Efficiency

Operational Efficiency

Returns Overview

Cash Flow Quality

Liquidity and Working Capital

Leverage and Coverage

Valuation Multiples

Dividend and Shareholder Yield

Peer companies